Interferon-λ signaling to maternal dendritic cells protects against congenital Zika virus infection
Science Advances · 2026
DOI: 10.1126/sciadv.aeh1073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Margaret R Dedloff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Zika Virus Infection, Dendritic Cells, Signal Transduction, Zika Virus. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Interferon-λ (IFN-λ, type III IFN) mediates antiviral immunity at anatomic barriers, including the maternal-fetal interface. To investigate the effects of IFN-λ during congenital Zika virus (ZIKV) infection, we infected mice lacking the IFN-αβ receptor ( Ifnar1 −/− ) or both the IFN-αβ and IFN-λ receptors ( Ifnar1 −/− Ifnlr1 −/− ) at embryonic day 9 and found that loss of maternal IFN-λ signaling resulted in greater transplacental transmission, highlighting a protective effect of IFN-λ at the maternal-fetal interface. To investigate the spatial relationship between ZIKV infection and antiviral responses, we used HiPlex RNAscope on the entire gravid uterus and found that IFN-λ was expressed more proximal to the site of ZIKV infection in Ifnar1 −/− dams compared to Ifnar1 −/− Ifnlr1 −/− dams. We performed immunophenotyping of the placenta and uterus by flow cytometry and found a decrease in dendritic cells and natural killer (NK) cells in the uterus of Ifnar1 −/− Ifnlr1 −/− dams compared to Ifnar1 −/− dams, but NK cell depletion did not affect fetal infection. Using conditional knockout mice, we identified maternal dendritic cells as the key IFN-λ–responsive cell type mediating protection against ZIKV congenital infection. Together, our data support a model in which IFN-λ signaling to maternal dendritic cells increases dendritic cell accumulation in the uterus, which facilitates a protective antiviral response that restricts ZIKV congenital infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Neuroscience Microscopy Core Facility, Carolina Institute for Developmental Disabilities & Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Histology Research Core Facility, Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
ORCID-Profile: Margaret R Dedloff, Tessa-Jonne F Ropp, Joel Rivera-Cardona, Celeste R Robles, Rebecca L Casazza, J Ashley Ezzell, Michelle S Itano, Helen M Lazear
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Dedloff, M. R., Reinhardt, T. R., Ropp, T. F., Rivera-Cardona, J., Robles, C. R., Casazza, R. L., Ezzell, J. A., Itano, M. S., & Lazear, H. M. (2026). Interferon-λ signaling to maternal dendritic cells protects against congenital Zika virus infection. Science Advances. https://doi.org/10.1126/sciadv.aeh1073
Vancouver
Dedloff MR, Reinhardt TR, Ropp TF, Rivera-Cardona J, Robles CR, Casazza RL, et al. Interferon-λ signaling to maternal dendritic cells protects against congenital Zika virus infection. Science Advances. 2026. doi:10.1126/sciadv.aeh1073
BibTeX
@article{Dedloff2026,
author = {Dedloff, Margaret R and Reinhardt, Thomas R and Ropp, Tessa-Jonne F and Rivera-Cardona, Joel and Robles, Celeste R and Casazza, Rebecca L and Ezzell, J Ashley and Itano, Michelle S and Lazear, Helen M},
title = {Interferon-λ signaling to maternal dendritic cells protects against congenital Zika virus infection},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh1073}
}
EUVIMED